BPS-314d-MR
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BPS-314d-MR, covering 2012-05-14 to 2012-05-14. Get the full timeline:
Most recent: Clinical Trial Update: A Multinational, Multicenter, Study to Assess the Efficacy and Safety of BPS-314d-MR in Subjects With Pulmonary Arterial Hypertension Currently Receiving Treatment With an Endothelin Receptor Antagonist and/or a Phosphodiesterase-5 Inhibitor [Phase 3]